policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
AVMA news
NC State, Purdue professors to join National Academy of Inventors
Kenneth Adler, PhD, professor of cell biology at North Carolina State University College of Veterinary Medicine’s Department of Molecular Biomedical…
AVMA news
New listings in AVMA Animal Health Studies Database – August 2022
A new study in the AVMA Animal Health Studies Database looks at a gene’s enzymatic activity in dogs with immune thrombocytopenia to further…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
AVMA news
VMX 2023 draws a crowd for 40th anniversary
Several new studies were unveiled at @the_NAVC Veterinary Meeting & Expo this January in Orlando, Florida, including research identifying 30 different…